In the News: Huge Hong Kong IPOs May be Imminent; Chinese Drugmakers to be Affected as US Lowers Drug Prices; and US House Passes Trade Secret Theft Bill

CATL and Ant Group’s planned listings could break recent HK IPO records; The lowering of U.S. drug prices will impact Chinese drugmakers; and U.S. House passes sanctions bill targeting trade secret theft by China.

By CLP staff

CATL and Ant Group Plan Hong Kong IPOs

Fintech giant Ant Group and battery giant CATL are planning to list in Hong Kong—listings that could potentially break recent world IPO records, sources say.

The international arm of Ant Group, Singapore-incorporated Ant International, is in talks with Hong Kong and Singapore regulators about plans for a Hong Kong IPO, according to an exclusive Caixin report.

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English

✓ Newsletters with business-critical and sector-specific updates

✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now